about
Seniors managing multiple medications: using mixed methods to view the home care safety lensRelationship Between Patients' Perceptions of Care Quality and Health Care Errors in 11 Countries: A Secondary Data AnalysisThe active patient role and asthma outcomes in an underserved rural communityValidation of four clinical indicators of preventable drug-related morbidity.Head office commitment to quality-related event reporting in community pharmacy.Qualitative evaluation of the Canadian Fabry Disease InitiativeDemystifying medication safety: making sense of the terminology.Pharmacist work stress and learning from quality related events.Workplace wellness programs in Canada: an exploration of key issues.Medication-related emergency department visits and hospital admissions in pediatric patients: a qualitative systematic review.A needs assessment of community pharmacists for pharmacist specialization in Canada.Minding the Gap: Factors Associated With Primary Care Coordination of Adults in 11 Countries.The professor is in.Ghosts of pharmacy past, present, and future.Strategies and policies to address the opioid epidemic: A case study of Ohio.A vision for hospital pharmacy in Canada.Medication-related emergency department visits in pediatrics: a prospective observational study.Viewing Pharmacy through a Public Health Lens.Part 1: Barriers to the advancement of the pharmacy professionPart 2: Roles and expertise needed to move the profession forward and improve health outcomes.Regulatory authority approaches to deploying quality improvement standards to community pharmacies: insights from the SafetyNET-RX program.Implications of process characteristics on quality-related event reporting in community pharmacy.The National Pharmaceuticals Strategy: Rest in peace, revive or renew?Part 3: Perspectives of pharmacy technicians on practice change.Adverse events in older patients admitted to acute care: a preliminary cost description.Part 5: Future vision for the pharmacy profession.Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees.ASHP/Association of Black Health-System Pharmacists Joint Leadership Award.Using the Health Belief Model to explain patient involvement in patient safety.Confirming delivery: understanding the role of the hospitalized patient in medication administration safety.Uptake of Quality-Related Event Standards of Practice by Community Pharmacies.Determinants of medication incident reporting, recovery, and learning in community pharmacies: a conceptual model.Emergency Physicians' Perception of Barriers and Facilitators for Adopting an Opioid Prescribing Guideline in Ohio: A Qualitative Interview StudyManagement Competencies for Canadian Health Executives: Views from the FieldExpansion of patient safety regulatory requirements in community pharmacy in Canada: The Melissa Sheldrick effect?Leadership training for pharmacistsOutcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic.Development of a list of consensus-approved clinical indicators of preventable drug-related morbidity in older adultsA comparison of factors used by physicians and patients in the selection of antidepressant agentsDisease management in Canada: surmounting barriers to adoption
P50
Q27307098-FE842A29-A17D-422B-8F19-DBB2FE69291CQ31037887-907A94B7-07A0-4F16-9BBD-E6D29C3F8815Q35083012-EA654A9D-ABA1-46F4-84AA-2E681A7309ECQ35638025-38E20D31-ED20-4F3F-ADAD-9CC62BDA84DBQ36595880-C754F917-DD87-4986-B0A3-CD99B9C3E9FCQ36595910-81889B97-3328-4D06-A6BB-4A7476FF5A42Q36670181-51FFD90D-1436-4107-ACBE-EC240ED34AE7Q37253294-E2D91B9C-4255-4580-8844-F00CFE5169E9Q37278378-2A86C2C6-7505-47FA-A687-2729D0EC2718Q38086970-37904AD5-4A88-44A6-895A-0028145917EEQ38834787-C9DC8884-73B7-4F17-A9FA-8E8CC8267685Q38910437-087B8B81-6933-4F72-8E3E-47C3A583A4F5Q39212846-D4EB5FB1-D7ED-4FE3-B123-37D4EF753327Q39632474-3BE00CC4-0C09-499E-B467-E5BC15D4B38DQ40339563-D3B8FEA0-F44D-4276-9BB1-E4C4A49E0B2CQ41125122-42133CD3-9BDA-4F2D-9AE4-C59E3B7301DDQ41485787-2F1B8603-F29D-40BF-A1B0-EA77E9F36F53Q41866068-C6056A1C-E221-4BC3-A20F-EC211EB4E5E1Q42094553-4A0C3AE7-C5FC-46D1-BA60-458415A6BB7CQ42289783-9723688D-B252-4BDC-9751-741F8769E69FQ42624602-2378325C-31CF-42F9-84DB-BE684395B11BQ42628731-619E0F3E-B23D-45CC-B53A-2FAB24DF4F83Q43149166-B23E7A7F-356E-49F6-BC20-3FDD095FF226Q46000590-B8D886EC-9964-4713-A061-B2915102D729Q46431560-1A420226-CF1F-4159-9DA5-4AD57238FA17Q47157650-AC2B8DC3-E9DC-4C6D-AE18-6D87F9509DCDQ47844683-EA170C60-0038-43F3-976C-70560B01BD85Q48261627-2172DB6E-1EFA-4938-8826-1FFDD202B7CFQ50315174-EE5B49C3-C855-4118-8E4C-95B0EF7C1308Q50656534-A2FD7E62-A6B8-4A58-8B72-09D2132B0E42Q50688110-107D9C09-265F-4B3C-8553-DBF49B52A03CQ51593169-0509F1C8-71E4-43D2-81AB-B987864B8DD8Q57813602-E84A2637-36FC-4D65-956C-65C5CC23FE3EQ59157760-EF2AE379-8086-4977-A230-FBE46DAE565DQ64253429-E176B834-95FE-43B0-BC89-26E4BA5D07BDQ64253432-8C5CC13D-31BD-48FF-8177-DDB9279FC162Q64897503-9F26905A-E5D1-4B53-BE41-D626D08968BFQ78601536-C92BB139-7B5A-415B-BC71-2AA04B5F8F9DQ79535144-DB6938AF-1F5A-4D43-BE34-44590130885EQ81047010-A5068909-F3B7-4EB7-9F8D-E9A0897E83B9
P50
description
researcher
@en
wetenschapper
@nl
name
Neil J MacKinnon
@en
Neil J MacKinnon
@nl
type
label
Neil J MacKinnon
@en
Neil J MacKinnon
@nl
prefLabel
Neil J MacKinnon
@en
Neil J MacKinnon
@nl
P106
P31
P496
0000-0001-8111-6651